PTC Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell PTCT and other ETFs, options, and stocks.

About PTCT

PTC Therapeutics, Inc. is a biopharmaceutical company, which focuses on the discovery, development, and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. The company was founded by Allan Steven Jacobson and Stuart Walter Peltz on March 31, 1998 and is headquartered in Warren, NJ.

CEO

Matthew B. Klein

CEOMatthew B. Klein

Employees

991

Employees991

Headquarters

Warren, New Jersey

HeadquartersWarren, New Jersey

Founded

1998

Founded1998

Employees

991

Employees991

PTCT Key Statistics

Market cap

5.64B

Market cap5.64B

Price-Earnings ratio

-114.53

Price-Earnings ratio-114.53

Dividend yield

—

Dividend yield—

Average volume

1.45M

Average volume1.45M

High today

$75.00

High today$75.00

Low today

$64.57

Low today$64.57

Open price

$72.81

Open price$72.81

Volume

4.33M

Volume4.33M

52 Week high

$90.87

52 Week high$90.87

52 Week low

$43.18

52 Week low$43.18

Stock Snapshot

PTC Therapeutics(PTCT) stock is priced at $69.24, giving the company a market capitalization of 5.64B. It carries a P/E multiple of -114.53.

On 2026-08-02, PTC Therapeutics(PTCT) stock traded between a low of $64.57 and a high of $75.00. Shares are currently priced at $69.24, which is +7.2% above the low and -7.7% below the high.

The PTC Therapeutics(PTCT)'s current trading volume is 4.33M, compared to an average daily volume of 1.45M.

During the past year, PTC Therapeutics(PTCT) stock moved between $43.18 at its lowest and $90.87 at its peak.

PTCT News

Simply Wall St 1d

PTC Therapeutics Stock Drops As Profit Surge Meets Launch Concentration Risk - simplywall.st

...

TipRanks 2d

PTC Therapeutics price target raised to $96 from $95 at BofA

BofA raised the firm’s price target on PTC Therapeutics (PTCT) to $96 from $95 and keeps a Buy rating on the shares. Unlock powerful investing tools with TipRa...

Nasdaq 2d

PTC Therapeutics Beats Q2 Earnings and Revenue Estimates

PTC Therapeutics (PTCT) came out with quarterly earnings of $0.92 per share, beating the Zacks Consensus Estimate of a loss of $0.17 per share. This compares to...

Analyst ratings

73%

of 15 ratings

Buy

73.3%

Hold

20%

Sell

6.7%

More PTCT News

TipRanks 2d

PTC Therapeutics Raises Outlook on Strong Q2 Results

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...

People also own

Based on the portfolios of people who own PTCT. This list is generated using Robinhood data, and it’s not a recommendation.

Taiwan Semiconductor Manu…

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.